Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Vaccines For Children (VFC) Market Growth 2021-2026

  • LP 4306464
  • 107 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Vaccines For Children (VFC) will have significant change from previous year. By the most conservative estimates of global Vaccines For Children (VFC) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccines For Children (VFC) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines For Children (VFC) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Government Institution

Private Sector

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

GSK

Sanofi

Merck

Pfizer

Jintan

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccines For Children (VFC) Consumption 2016-2026

2.1.2 Vaccines For Children (VFC) Consumption CAGR by Region

2.2 Vaccines For Children (VFC) Segment by Type

2.2.1 Recombinant Vaccines

2.2.2 Viral Vaccines

2.2.3 Polysaccharide Vaccines

2.2.4 Others

2.3 Vaccines For Children (VFC) Sales by Type

2.3.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

2.3.2 Global Vaccines For Children (VFC) Revenue and Market Share by Type (2016-2021)

2.3.3 Global Vaccines For Children (VFC) Sale Price by Type (2016-2021)

2.4 Vaccines For Children (VFC) Segment by Application

2.4.1 Government Institution

2.4.2 Private Sector

2.4.3 Other

2.5 Vaccines For Children (VFC) Sales by Application

2.5.1 Global Vaccines For Children (VFC) Sale Market Share by Application (2016-2021)

2.5.2 Global Vaccines For Children (VFC) Revenue and Market Share by Application (2016-2021)

2.5.3 Global Vaccines For Children (VFC) Sale Price by Application (2016-2021)

3 Global Vaccines For Children (VFC) by Company

3.1 Global Vaccines For Children (VFC) Sales Market Share by Company

3.1.1 Global Vaccines For Children (VFC) Sales by Company (2019-2021)

3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Company (2019-2021)

3.2 Global Vaccines For Children (VFC) Revenue Market Share by Company

3.2.1 Global Vaccines For Children (VFC) Revenue by Company (2019-2021)

3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Company (2019-2021)

3.3 Global Vaccines For Children (VFC) Sale Price by Company

3.4 Global Manufacturers Vaccines For Children (VFC) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccines For Children (VFC) Product Location Distribution

3.4.2 Players Vaccines For Children (VFC) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Vaccines For Children (VFC) by Region

4.1 Global Vaccines For Children (VFC) by Region

4.1.1 Global Vaccines For Children (VFC) Sales by Region

4.1.2 Global Vaccines For Children (VFC) Revenue by Region

4.2 Americas Vaccines For Children (VFC) Sales Growth

4.3 APAC Vaccines For Children (VFC) Sales Growth

4.4 Europe Vaccines For Children (VFC) Sales Growth

4.5 Middle East & Africa Vaccines For Children (VFC) Sales Growth

5 Americas

5.1 Americas Vaccines For Children (VFC) Sales by Country

5.1.1 Americas Vaccines For Children (VFC) Sales by Country (2016-2021)

5.1.2 Americas Vaccines For Children (VFC) Revenue by Country (2016-2021)

5.2 Americas Vaccines For Children (VFC) Sales by Type

5.3 Americas Vaccines For Children (VFC) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccines For Children (VFC) Sales by Region

6.1.1 APAC Vaccines For Children (VFC) Sales by Region (2016-2021)

6.1.2 APAC Vaccines For Children (VFC) Revenue by Region (2016-2021)

6.2 APAC Vaccines For Children (VFC) Sales by Type

6.3 APAC Vaccines For Children (VFC) Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Vaccines For Children (VFC) by Country

7.1.1 Europe Vaccines For Children (VFC) Sales by Country (2016-2021)

7.1.2 Europe Vaccines For Children (VFC) Revenue by Country (2016-2021)

7.2 Europe Vaccines For Children (VFC) Sales by Type

7.3 Europe Vaccines For Children (VFC) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccines For Children (VFC) by Country

8.1.1 Middle East & Africa Vaccines For Children (VFC) Sales by Country (2016-2021)

8.1.2 Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2016-2021)

8.2 Middle East & Africa Vaccines For Children (VFC) Sales by Type

8.3 Middle East & Africa Vaccines For Children (VFC) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Vaccines For Children (VFC) Distributors

10.3 Vaccines For Children (VFC) Customer

11 Global Vaccines For Children (VFC) Market Forecast

11.1 Global Vaccines For Children (VFC) Forecast by Region

11.1.1 Global Vaccines For Children (VFC) Forecast by Regions (2021-2026)

11.2.2 Global Vaccines For Children (VFC) Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Vaccines For Children (VFC) Forecast by Type

11.7 Global Vaccines For Children (VFC) Forecast by Application

12 Key Players Analysis

12.1 GSK

12.1.1 GSK Company Information

12.1.2 GSK Vaccines For Children (VFC) Product Offered

12.1.3 GSK Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 GSK Main Business Overview

12.1.5 GSK Latest Developments

12.2 Sanofi

12.2.1 Sanofi Company Information

12.2.2 Sanofi Vaccines For Children (VFC) Product Offered

12.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Sanofi Main Business Overview

12.2.5 Sanofi Latest Developments

12.3 Merck

12.3.1 Merck Company Information

12.3.2 Merck Vaccines For Children (VFC) Product Offered

12.3.3 Merck Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Merck Main Business Overview

12.3.5 Merck Latest Developments

12.4 Pfizer

12.4.1 Pfizer Company Information

12.4.2 Pfizer Vaccines For Children (VFC) Product Offered

12.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Pfizer Main Business Overview

12.4.5 Pfizer Latest Developments

12.5 Jintan

12.5.1 Jintan Company Information

12.5.2 Jintan Vaccines For Children (VFC) Product Offered

12.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Jintan Main Business Overview

12.5.5 Jintan Latest Developments

12.6 CSL

12.6.1 CSL Company Information

12.6.2 CSL Vaccines For Children (VFC) Product Offered

12.6.3 CSL Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 CSL Main Business Overview

12.6.5 CSL Latest Developments

12.7 MedImmune LLC

12.7.1 MedImmune LLC Company Information

12.7.2 MedImmune LLC Vaccines For Children (VFC) Product Offered

12.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 MedImmune LLC Main Business Overview

12.7.5 MedImmune LLC Latest Developments

12.8 J&J(Crucell)

12.8.1 J&J(Crucell) Company Information

12.8.2 J&J(Crucell) Vaccines For Children (VFC) Product Offered

12.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 J&J(Crucell) Main Business Overview

12.8.5 J&J(Crucell) Latest Developments

12.9 China National Biotec

12.9.1 China National Biotec Company Information

12.9.2 China National Biotec Vaccines For Children (VFC) Product Offered

12.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 China National Biotec Main Business Overview

12.9.5 China National Biotec Latest Developments

12.10 Tiantan

12.10.1 Tiantan Company Information

12.10.2 Tiantan Vaccines For Children (VFC) Product Offered

12.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Tiantan Main Business Overview

12.10.5 Tiantan Latest Developments

12.11 Hualan

12.11.1 Hualan Company Information

12.11.2 Hualan Vaccines For Children (VFC) Product Offered

12.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Hualan Main Business Overview

12.11.5 Hualan Latest Developments

12.12 Kangtai

12.12.1 Kangtai Company Information

12.12.2 Kangtai Vaccines For Children (VFC) Product Offered

12.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Kangtai Main Business Overview

12.12.5 Kangtai Latest Developments

12.13 Hissen

12.13.1 Hissen Company Information

12.13.2 Hissen Vaccines For Children (VFC) Product Offered

12.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Hissen Main Business Overview

12.13.5 Hissen Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Vaccines For Children (VFC) Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Recombinant Vaccines

Table 3. Major Players of Viral Vaccines

Table 4. Major Players of Polysaccharide Vaccines

Table 5. Major Players of Others

Table 6. Global Vaccines For Children (VFC) Sales by Type (2016-2021) & (K Doses)

Table 7. Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

Table 8. Global Vaccines For Children (VFC) Revenue by Type (2016-2021) & ($ million)

Table 9. Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021)

Table 10. Global Vaccines For Children (VFC) Sale Price by Type (2016-2021)

Table 11. Global Vaccines For Children (VFC) Sales by Application (2016-2021) & (K Doses)

Table 12. Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Table 13. Global Vaccines For Children (VFC) Value by Application (2016-2021)

Table 14. Global Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021)

Table 15. Global Vaccines For Children (VFC) Sale Price by Application (2016-2021)

Table 16. Global Vaccines For Children (VFC) Sales by Company (2019-2021) & (K Doses)

Table 17. Global Vaccines For Children (VFC) Sales Market Share by Company (2019-2021)

Table 18. Global Vaccines For Children (VFC) Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Vaccines For Children (VFC) Revenue Market Share by Company (2019-2021)

Table 20. Global Vaccines For Children (VFC) Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution and Sales Area

Table 22. Players Vaccines For Children (VFC) Products Offered

Table 23. Vaccines For Children (VFC) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Vaccines For Children (VFC) Sales by Region (2016-2021) (K Doses)

Table 27. Global Vaccines For Children (VFC) Sales Market Share by Region (2016-2021)

Table 28. Global Vaccines For Children (VFC) Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021)

Table 30. Americas Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)

Table 31. Americas Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)

Table 32. Americas Vaccines For Children (VFC) Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)

Table 34. Americas Vaccines For Children (VFC) Sales by Type (2016-2021) & (K Doses)

Table 35. Americas Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

Table 36. Americas Vaccines For Children (VFC) Sales by Application (2016-2021) & (K Doses)

Table 37. Americas Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Table 38. APAC Vaccines For Children (VFC) Sales by Region (2016-2021) & (K Doses)

Table 39. APAC Vaccines For Children (VFC) Sales Market Share by Region (2016-2021)

Table 40. APAC Vaccines For Children (VFC) Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021)

Table 42. APAC Vaccines For Children (VFC) Sales by Type (2016-2021) & (K Doses)

Table 43. APAC Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

Table 44. APAC Vaccines For Children (VFC) Sales by Application (2016-2021) & (K Doses)

Table 45. APAC Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Table 46. Europe Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)

Table 47. Europe Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)

Table 48. Europe Vaccines For Children (VFC) Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)

Table 50. Europe Vaccines For Children (VFC) Sales by Type (2016-2021) & (K Doses)

Table 51. Europe Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

Table 52. Europe Vaccines For Children (VFC) Sales by Application (2016-2021) & (K Doses)

Table 53. Europe Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)

Table 55. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2016-2021) & (K Doses)

Table 59. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2016-2021) & (K Doses)

Table 61. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Vaccines For Children (VFC)

Table 63. Key Application and Potential Industries of Vaccines For Children (VFC)

Table 64. Key Challenges of Vaccines For Children (VFC)

Table 65. Key Trends of Vaccines For Children (VFC)

Table 66. Vaccines For Children (VFC) Distributors List

Table 67. Vaccines For Children (VFC) Customer List

Table 68. Global Vaccines For Children (VFC) Sales Forecast by Region (2021-2026) & (K Doses)

Table 69. Global Vaccines For Children (VFC) Consumption Market Forecast by Region

Table 70. Global Vaccines For Children (VFC) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Vaccines For Children (VFC) Sales Forecast by Country (2021-2026) & (K Doses)

Table 73. Americas Vaccines For Children (VFC) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Vaccines For Children (VFC) Sales Forecast by Region (2021-2026) & (K Doses)

Table 75. APAC Vaccines For Children (VFC) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Vaccines For Children (VFC) Sales Forecast by Country (2021-2026) & (K Doses)

Table 77. Europe Vaccines For Children (VFC) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Vaccines For Children (VFC) Sales Forecast by Country (2021-2026) & (K Doses)

Table 79. Middle East & Africa Vaccines For Children (VFC) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Vaccines For Children (VFC) Sales Forecast by Type (2021-2026) & (K Doses)

Table 81. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Vaccines For Children (VFC) Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Vaccines For Children (VFC) Sales Forecast by Application (2021-2026) & (K Doses)

Table 85. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Vaccines For Children (VFC) Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2021-2026)

Table 88. GSK Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 89. GSK Vaccines For Children (VFC) Product Offered

Table 90. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 91. GSK Main Business

Table 92. GSK Latest Developments

Table 93. Sanofi Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Vaccines For Children (VFC) Product Offered

Table 95. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Merck Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck Vaccines For Children (VFC) Product Offered

Table 100. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 101. Merck Main Business

Table 102. Merck Latest Developments

Table 103. Pfizer Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Vaccines For Children (VFC) Product Offered

Table 105. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Jintan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 109. Jintan Vaccines For Children (VFC) Product Offered

Table 110. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 111. Jintan Main Business

Table 112. Jintan Latest Developments

Table 113. CSL Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 114. CSL Vaccines For Children (VFC) Product Offered

Table 115. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 116. CSL Main Business

Table 117. CSL Latest Developments

Table 118. MedImmune LLC Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 119. MedImmune LLC Vaccines For Children (VFC) Product Offered

Table 120. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 121. MedImmune LLC Main Business

Table 122. MedImmune LLC Latest Developments

Table 123. J&J(Crucell) Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 124. J&J(Crucell) Vaccines For Children (VFC) Product Offered

Table 125. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 126. J&J(Crucell) Main Business

Table 127. J&J(Crucell) Latest Developments

Table 128. China National Biotec Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 129. China National Biotec Vaccines For Children (VFC) Product Offered

Table 130. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 131. China National Biotec Main Business

Table 132. China National Biotec Latest Developments

Table 133. Tiantan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 134. Tiantan Vaccines For Children (VFC) Product Offered

Table 135. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 136. Tiantan Main Business

Table 137. Tiantan Latest Developments

Table 138. Hualan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 139. Hualan Vaccines For Children (VFC) Product Offered

Table 140. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 141. Hualan Main Business

Table 142. Hualan Latest Developments

Table 143. Kangtai Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 144. Kangtai Vaccines For Children (VFC) Product Offered

Table 145. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 146. Kangtai Main Business

Table 147. Kangtai Latest Developments

Table 148. Hissen Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 149. Hissen Vaccines For Children (VFC) Product Offered

Table 150. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 151. Hissen Main Business

Table 152. Hissen Latest Developments

List of Figures

Figure 1. Picture of Vaccines For Children (VFC)

Figure 2. Vaccines For Children (VFC) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccines For Children (VFC) Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Vaccines For Children (VFC) Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Vaccines For Children (VFC) Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Recombinant Vaccines

Figure 10. Product Picture of Viral Vaccines

Figure 11. Product Picture of Polysaccharide Vaccines

Figure 12. Product Picture of Others

Figure 13. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020

Figure 14. Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021)

Figure 15. Vaccines For Children (VFC) Consumed in Government Institution

Figure 16. Global Vaccines For Children (VFC) Market: Government Institution (2016-2021) & (K Doses)

Figure 17. Vaccines For Children (VFC) Consumed in Private Sector

Figure 18. Global Vaccines For Children (VFC) Market: Private Sector (2016-2021) & (K Doses)

Figure 19. Vaccines For Children (VFC) Consumed in Other

Figure 20. Global Vaccines For Children (VFC) Market: Other (2016-2021) & (K Doses)

Figure 21. Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)

Figure 22. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2020

Figure 23. Vaccines For Children (VFC) Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Vaccines For Children (VFC) Revenue Market Share by Company in 2020

Figure 25. Global Vaccines For Children (VFC) Sales Market Share by Regions (2016-2021)

Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Region in 2020

Figure 27. Americas Vaccines For Children (VFC) Sales 2016-2021 (K Doses)

Figure 28. Americas Vaccines For Children (VFC) Revenue 2016-2021 ($ Millions)

Figure 29. APAC Vaccines For Children (VFC) Sales 2016-2021 (K Doses)

Figure 30. APAC Vaccines For Children (VFC) Revenue 2016-2021 ($ Millions)

Figure 31. Europe Vaccines For Children (VFC) Sales 2016-2021 (K Doses)

Figure 32. Europe Vaccines For Children (VFC) Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Vaccines For Children (VFC) Sales 2016-2021 (K Doses)

Figure 34. Middle East & Africa Vaccines For Children (VFC) Revenue 2016-2021 ($ Millions)

Figure 35. Americas Vaccines For Children (VFC) Sales Market Share by Country in 2020

Figure 36. Americas Vaccines For Children (VFC) Revenue Market Share by Country in 2020

Figure 37. Americas Vaccines For Children (VFC) Sales Market Share by Type in 2020

Figure 38. Americas Vaccines For Children (VFC) Sales Market Share by Application in 2020

Figure 39. United States Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Vaccines For Children (VFC) Sales Market Share by Region in 2020

Figure 44. APAC Vaccines For Children (VFC) Revenue Market Share by Regions in 2020

Figure 45. APAC Vaccines For Children (VFC) Sales Market Share by Type in 2020

Figure 46. APAC Vaccines For Children (VFC) Sales Market Share by Application in 2020

Figure 47. China Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2020

Figure 54. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2020

Figure 55. Europe Vaccines For Children (VFC) Sales Market Share by Type in 2020

Figure 56. Europe Vaccines For Children (VFC) Sales Market Share by Application in 2020

Figure 57. Germany Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application in 2020

Figure 66. Egypt Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Vaccines For Children (VFC) Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370